BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16424038)

  • 1. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer.
    Zhang Y; Banerjee S; Wang Z; Xu H; Zhang L; Mohammad R; Aboukameel A; Adsay NV; Che M; Abbruzzese JL; Majumdar AP; Sarkar FH
    Cancer Res; 2006 Jan; 66(2):1025-32. PubMed ID: 16424038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
    Xu H; Yu Y; Marciniak D; Rishi AK; Sarkar FH; Kucuk O; Majumdar AP
    Mol Cancer Ther; 2005 Mar; 4(3):435-42. PubMed ID: 15767552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer.
    Wang Z; Sengupta R; Banerjee S; Li Y; Zhang Y; Rahman KM; Aboukameel A; Mohammad R; Majumdar AP; Abbruzzese JL; Sarkar FH
    Cancer Res; 2006 Aug; 66(15):7653-60. PubMed ID: 16885366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells.
    Zhang Y; Banerjee S; Wang ZW; Marciniak DJ; Majumdar AP; Sarkar FH
    Cancer Res; 2005 May; 65(9):3877-82. PubMed ID: 15867387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells.
    Marciniak DJ; Rishi AK; Sarkar FH; Majumdar AP
    Mol Cancer Ther; 2004 Dec; 3(12):1615-21. PubMed ID: 15634655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy.
    Ali S; El-Rayes BF; Sarkar FH; Philip PA
    Mol Cancer Ther; 2005 Dec; 4(12):1943-51. PubMed ID: 16373709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ERRP in normal and neoplastic pancreata and its relationship to clinicopathologic parameters in pancreatic adenocarcinoma.
    Feng J; Adsay NV; Kruger M; Ellis KL; Nagothu K; Majumdar AP; Sarkar FH
    Pancreas; 2002 Nov; 25(4):342-9. PubMed ID: 12409827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of epidermal growth factor receptor related protein in gastric cancer.
    Moon WS; Tarnawski AS; Chai J; Yang JT; Majumdar AP
    Gut; 2005 Feb; 54(2):201-6. PubMed ID: 15647181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of early and intermediate stages of colon cancer by targeting multiple members of the EGFR family with EGFR-related protein.
    Schmelz EM; Xu H; Sengupta R; Du J; Banerjee S; Sarkar FH; Rishi AK; Majumdar AP
    Cancer Res; 2007 Jun; 67(11):5389-96. PubMed ID: 17545620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells.
    Reddy S; Rishi AK; Xu H; Levi E; Sarkar FH; Majumdar AP
    Nutr Cancer; 2006; 55(2):185-94. PubMed ID: 17044774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Triazenoazaindoles: α novel class of triazenes inducing transcriptional down-regulation of EGFR and HER-2 in human pancreatic cancer cells.
    Kreutzer JN; Salvador A; Diana P; Cirrincione G; Vedaldi D; Litchfield DW; Issinger OG; Guerra B
    Int J Oncol; 2012 Apr; 40(4):914-22. PubMed ID: 22134789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning of a novel EGFR-related peptide: a putative negative regulator of EGFR.
    Yu Y; Rishi AK; Turner JR; Liu D; Black ED; Moshier JA; Majumdar AP
    Am J Physiol Cell Physiol; 2001 May; 280(5):C1083-9. PubMed ID: 11287320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational research of a novel humanized epidermal growth factor receptor-related protein: a putative inhibitor of pan-ErbB.
    Fu XH; Li J; Huang JJ; Zheng S; Zhang SZ
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1373-6. PubMed ID: 21947130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of EGFR-related protein, a universal EGFR family antagonist.
    Majumdar AP
    Future Oncol; 2005 Apr; 1(2):235-45. PubMed ID: 16555995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
    Singh S; Shi Q; Bailey ST; Palczewski MJ; Pardee AB; Iglehart JD; Biswas DK
    Mol Cancer Ther; 2007 Jul; 6(7):1973-82. PubMed ID: 17620428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of epidermal growth factor receptor-related protein in hepatocellular carcinoma: implications for cancer growth.
    Moon WS; Chang KJ; Majumdar AP; Tarnawski AS
    Digestion; 2004; 69(4):219-24. PubMed ID: 15205570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGF receptor-related protein (ERRP) inhibits invasion of colon cancer cells and tubule formation by endothelial cells in vitro.
    Rishi AK; Parikh R; Wali A; Durko L; Zhang L; Yu Y; Majumdar AP
    Anticancer Res; 2006; 26(2A):1029-37. PubMed ID: 16619503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapies in gastrointestinal cancers.
    Nautiyal J; Rishi AK; Majumdar AP
    World J Gastroenterol; 2006 Dec; 12(46):7440-50. PubMed ID: 17167831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Ueda S; Ogata S; Tsuda H; Kawarabayashi N; Kimura M; Sugiura Y; Tamai S; Matsubara O; Hatsuse K; Mochizuki H
    Pancreas; 2004 Jul; 29(1):e1-8. PubMed ID: 15211117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
    Mill CP; Gettinger KL; Riese DJ
    Exp Cell Res; 2011 Feb; 317(4):392-404. PubMed ID: 21110957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.